JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
JPUS
3726
JPMorgan Diversified Return US Equity ETF
JPUS
$450M
| $913K | ﹤0.01% |
12,020
+90
| +0.8% | +$6.76K |
2015 Q4
15 quarters
|
|
3727
Franklin Electric
FELE
$4.27B
| $911K | ﹤0.01% |
19,057
-12,058
| -39% | -$558K |
2013 Q2
25 quarters
|
|
|
NETI
3728
DELISTED
Eneti Inc.
NETI
| $911K | ﹤0.01% |
16,123
-35,125
| -69% | -$1.97M |
2017 Q4
7 quarters
|
|
3729
CALL
CNX Resources
CNX
$4.66B
| $908K | ﹤0.01% |
+125,000
| New | +$936K |
2019 Q3
0 quarters
|
|
|
PS
3730
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $908K | ﹤0.01% |
54,015
-2,746,885
| -98% | -$59.2M |
2018 Q2
5 quarters
|
|
3731
Ultragenyx Pharmaceutical
RARE
$1.45B
| $906K | ﹤0.01% |
21,156
+3,107
| +17% | +$169K |
2014 Q1
22 quarters
|
|
3732
NETGEAR
NTGR
$622M
| $900K | ﹤0.01% |
27,919
-66,816
| -71% | -$2.1M |
2013 Q2
25 quarters
|
|
3733
Sutro Biopharma
STRO
$265M
| $896K | ﹤0.01% |
9,854
+350
| +4% | +$35.3K |
2018 Q3
4 quarters
|
|
|
PVTL
3734
CALL
DELISTED
Pivotal Software, Inc.
PVTL
| $892K | ﹤0.01% |
59,800
+26,300
| +79% | +$322K |
2019 Q2
1 quarter
|
|
|
BIG
3735
DELISTED
Big Lots, Inc.
BIG
| $890K | ﹤0.01% |
36,310
-13,703
| -27% | -$326K |
2013 Q2
25 quarters
|
|
|
NBRV
3736
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $886K | ﹤0.01% |
1,773
+478
| +37% | +$270K |
2018 Q3
4 quarters
|
|
|
BSCN
3737
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $886K | ﹤0.01% |
41,620
+23,508
| +130% | +$499K |
2018 Q1
6 quarters
|
|
|
USX
3738
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $885K | ﹤0.01% |
183,415
+157,361
| +604% | +$716K |
2018 Q2
5 quarters
|
|
3739
LCNB Corp
LCNB
$268M
| $879K | ﹤0.01% |
49,524
+7,896
| +19% | +$138K |
2017 Q4
7 quarters
|
|
|
PMBC
3740
DELISTED
Pacific Mercantile Bancorp
PMBC
| $879K | ﹤0.01% |
116,952
+2,434
| +2% | +$19.1K |
2016 Q4
11 quarters
|
|
|
ABB
3741
DELISTED
ABB Ltd
ABB
| $875K | ﹤0.01% |
44,526
+2,351
| +6% | +$44.8K |
2013 Q2
25 quarters
|
|
3742
Pacira BioSciences
PCRX
$997M
| $874K | ﹤0.01% |
22,950
-135,063
| -85% | -$5.39M |
2013 Q2
25 quarters
|
|
3743
ROBO Global Robotics & Automation Index ETF
ROBO
$2.04B
| $873K | ﹤0.01% |
22,769
-3,534
| -13% | -$133K |
2017 Q2
9 quarters
|
|
3744
Citizens & Northern Corp
CZNC
$452M
| $872K | ﹤0.01% |
33,182
-19,237
| -37% | -$481K |
2013 Q2
25 quarters
|
|
3745
SFL Corp
SFL
$1.87B
| $867K | ﹤0.01% |
61,791
-35,307
| -36% | -$474K |
2015 Q4
15 quarters
|
|
3746
Global X FinTech ETF
FINX
$156M
| $864K | ﹤0.01% |
30,031
+16,678
| +125% | +$491K |
2019 Q2
1 quarter
|
|
3747
iShares MSCI Malaysia ETF
EWM
$282M
| $861K | ﹤0.01% |
30,940
-6,198
| -17% | -$177K |
2013 Q2
25 quarters
|
|
3748
National Healthcare
NHC
$3.5B
| $861K | ﹤0.01% |
10,525
+7,168
| +214% | +$593K |
2016 Q3
12 quarters
|
|
3749
Northern Oil and Gas
NOG
$2.51B
| $861K | ﹤0.01% |
43,950
+2,387
| +6% | +$43.8K |
2015 Q4
15 quarters
|
|
3750
CALL
NeoGenomics
NEO
$2.28B
| $860K | ﹤0.01% |
+45,000
| New | +$1.06M |
2019 Q3
0 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.